OTC : DRMTY
$0 (0.0%)
OTC
Ije Nwokorie
Apparel - Footwear & Accessories
Consumer Cyclical
DRMTY
2377
GB
USD
1.09
2.61
1.60
1.13
1.03
$764.9M
1.05
2.21
6.88
0.24
$0.048
$23.8M
3.11%
4.28%
6.89%
2.71%
33.57
0.07
0.07
3/5
0 Analysts
%
6.22
6/9
$257.21M
$877.34M
$515.83M
$115.49M
$1.01B
1.32
6.98
2.61
6.89%
7.30%
2.97%
14.53%
$0.46
174 days
| Name | Title |
|---|---|
| Onyeije Ogueri Nwokorie | Chief Executive Officer & Executive Director |
| Anna Duffiet | Interim Chief Operations Officer |
| Mike Stopforth | Chief Commercial Officer |
| Katherine Bellau | Chief Legal Officer & Company Secretary |
| Graham Calder | Chief Technology Officer |
| Derek Chan | President of APAC |
| Giles Robert Bryant Wilson | Chief Financial Officer & Director |
| Sean O'Neill | Chief Digital Officer |
| Bethany Barnes | Director of Investor Relations & Corporate Communications |
| Bridget Jolliffe | Chief People Officer |
No votes yet today — be the first to share your view!
About Dr. Martens plc (OTC:DRMTY) Stock
Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom. ...
Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
2026-05-19 12:11:00
Dr. Martens plc (DRMTY) Q4 2026 Earnings Call Transcript
Dr Martens profits jump as turnaround gains grip
2026-05-19 02:53:41
Dr Martens PLC (LSE:DOCS) returned to profit growth last year as the bootmaker tightened discounting, improved margins and pushed ahead with a turnaround centred on higher-quality sales. The FTSE 250-listed group reported an adjusted pre-tax profit of £55 million in the year to 29 March, up 61% on the year before, while revenue fell 2.9% to £764.9 million.
Dr Martens' turnaround gathers pace as annual profit jumps 61%
2026-05-19 02:19:46
Dr Martens reported a 61% jump in annual earnings on Tuesday and forecast "strong profit" growth this fiscal year as the British bootmaker's strategy of cutting discounts and improving margins appeared to be paying off.
Frequently Asked Questions
What is the current Dr. Martens plc (DRMTY) stock price?
Dr. Martens plc(OTC:DRMTY) stock price is $2.08 in the last trading session. During the trading session, DRMTY stock reached the peak price of $2.13 while $1.8 was the lowest point it dropped to. The percentage change in DRMTY stock occurred in the recent session was 0.0% while the dollar amount for the price change in DRMTY stock was $0.
DRMTY's industry and sector of operation?
The OTC listed DRMTY is part of Apparel - Footwear & Accessories industry that operates in the broader Consumer Cyclical sector.
Who are the executives of DRMTY?
Onyeije Ogueri Nwokorie
| Chief Executive Officer & Executive Director
Anna Duffiet
| Interim Chief Operations Officer
Mike Stopforth
| Chief Commercial Officer
Katherine Bellau
| Chief Legal Officer & Company Secretary
Graham Calder
| Chief Technology Officer
How many employees does DRMTY have?
Number of DRMTY employees currently stands at 2377. DRMTY operates from 28 Jamestown Road, London, GL NW1 7BY, GB.
Link for DRMTY official website?
Official Website of DRMTY is: https://www.drmartensplc.com
How do I contact DRMTY?
DRMTY could be contacted at phone #44 12 1415 7047 and can also be accessed through its website. DRMTY operates from 28 Jamestown Road, London, GL NW1 7BY, GB.
How many shares of DRMTY are traded daily?
The average number of DRMTY shares traded daily for last 3 months was 1.45K.
What is the market cap of DRMTY currently?
The market value of DRMTY currently stands at $995.4M with its latest stock price at $2.08